BeyondSpring (BYSI) Current Assets (2015 - 2026)
BeyondSpring's (BYSI) quarterly Current Assets came in at $9.9 million in Q2 2026, down 61.49% year-over-year from $25.7 million in Q2 2025, and down 26.68% quarter-over-quarter from $13.5 million in Q1 2026.
Analysis
BeyondSpring (BYSI) Current Assets (2015 - 2026) Analysis & Trends
BeyondSpring has disclosed Current Assets across 12 years of filings, most recently posting $9.9 million for Q2 2026.
- In Q2 2026, Current Assets fell 61.49% year-over-year to $9.9 million; the TTM figure through Jun 2026 stood at $9.9 million (down 61.49% YoY), while the FY2025 annual figure was $20.9 million, down 26.93% from the prior year.
- Current Assets came in at $9.9 million for Q2 2026 at BeyondSpring, down from $13.5 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $55.7 million in Q2 2022 to a low of $9.9 million in Q2 2026.
- Average Current Assets over 5 years is $25.7 million, with a median of $25.1 million recorded in 2025.
- Year-over-year, Current Assets soared 72.34% in 2025 and slumped 61.49% in 2026.
- Over 5 years, Current Assets stood at $38.5 million in 2022, then tumbled by 52.19% to $18.4 million in 2023, then soared by 55.15% to $28.6 million in 2024, then slipped by 26.93% to $20.9 million in 2025, then slumped by 52.59% to $9.9 million in 2026.
- Per Business Quant data, the three most recent Current Assets figures were $9.9 million in Q2 2026, $13.5 million in Q1 2026, and $20.9 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | 41.36 Bn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | 36.64 Bn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | 4.03 Bn |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | 6.03 Bn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | 3.48 Bn |
| 10 | BeyondSpring | 31.51 Mn | 31.51 Mn | - | 9.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.90 Mn |
| Mar 31, 2026 | 13.50 Mn |
| Dec 31, 2025 | 20.88 Mn |
| Sep 30, 2025 | 24.41 Mn |
| Jun 30, 2025 | 25.71 Mn |
| Mar 31, 2025 | 31.53 Mn |
| Dec 31, 2024 | 28.58 Mn |
| Jun 30, 2024 | 14.92 Mn |
| Dec 31, 2023 | 18.42 Mn |
| Jun 30, 2023 | 25.79 Mn |
| Dec 31, 2022 | 38.52 Mn |
| Jun 30, 2022 | 55.73 Mn |
| Dec 31, 2021 | 75.12 Mn |
| Sep 30, 2021 | 94.67 Mn |
| Jun 30, 2021 | 79.84 Mn |
| Mar 31, 2021 | 94.37 Mn |
| Dec 31, 2020 | 113.40 Mn |
| Sep 30, 2020 | 35.69 Mn |
| Jun 30, 2020 | 42.98 Mn |
| Mar 31, 2020 | 29.75 Mn |